Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the Answer of 3 December 2014 to Question 216468, what progress he has made in establishing trials for pancreatic cancer patients using stereotactic ablative radiotherapy.

Cancer Research UK is funding the SPARC trial, which is led by the University of Oxford. This is a phase I trial of pre-operative, margin intensive, stereotactic body radiation therapy for previously untreated borderline resectable pancreatic cancer. The National Institute for Health Research (NIHR) Clinical Research Network is providing research infrastructure for the trial.